TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32376702

Group type: EXPERIMENTAL
Intervention: Bezlotoxumab treatment
Number of subjects: 704
Study: 36282273

Group type: EXPERIMENTAL
Intervention: Peer-modeled mindset intervention using videotaped interviews of former students.
Number of subjects: 917
Study: 33531453

Group type: EXPERIMENTAL
Intervention: Beraprost sodium combined with sildenafil
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 80
Study: 35942813

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.25 mcg OD)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Calcitriol
Number of subjects: 127
Study: 33650888

Group type: EXPERIMENTAL
Intervention: Family-Based Intervention (FBI) program
Number of subjects: 130

Group type: COMPARATOR
Intervention: Education-only (EDU) group
Number of subjects: 130
Study: 34819261

Group type: EXPERIMENTAL
Intervention: Serratus Anterior Plane Block (SAPB)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Intercostal Block with Incision Infiltration (IB+II)
Number of subjects: 65
Study: 32422685

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 614

Group type: COMPARATOR
Intervention: Healthy lifestyles (HL)
Number of subjects: 614
Study: 36076231

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy Skills Intervention (CBTSI)
Number of subjects: 60
Study: 35270556

Group type: EXPERIMENTAL
Intervention: 3 mg/kg of caffeine (CAF-3)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 6 mg/kg of caffeine (CAF-6)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 10
Study: 33369068

Group type: EXPERIMENTAL
Intervention: Outdoor exercise sessions
Number of subjects: 16

Group type: COMPARATOR
Intervention: Indoor exercise sessions
Number of subjects: 16
Study: 35025174

Group type: EXPERIMENTAL
Intervention: Oh Happy Day Class (OHDC)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Coping with Depression (CWD)
Number of subjects: 132
Study: 32977741

Group type: EXPERIMENTAL
Intervention: FibroScan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VTQ
Number of subjects: 0

Group type: COMPARATOR
Intervention: FIB-4 index
Number of subjects: 0

Group type: COMPARATOR
Intervention: M2BPGi
Number of subjects: 0
Study: 35933224

Group type: EXPERIMENTAL
Intervention: Neutrophil-to-lymphocyte ratio (NLR)
Number of subjects: 0
Study: 32299437

Group type: EXPERIMENTAL
Intervention: Non-incentivised Test n Treat
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Incentivised Test n Treat
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Projected daily capacity for screening
Number of subjects: 509
Study: 35134221

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 0
Study: 32179560

Group type: EXPERIMENTAL
Intervention: Early adenotonsillectomy (AT)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Watchful waiting with supportive care (WWSC)
Number of subjects: 460
Study: 34392411

Group type: EXPERIMENTAL
Intervention: 1000 IU of daily vitamin D3
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 4000 IU of daily vitamin D3
Number of subjects: 98
Study: 32718193

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol as maintenance and reliever therapy
Number of subjects: 2010

Group type: COMPARATOR
Intervention: Budesonide/formoterol maintenance plus terbutaline as reliever
Number of subjects: 2010
Study: 34001426

Group type: EXPERIMENTAL
Intervention: Experimental Intervention Group (EIG)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control Intervention Group (CIG)
Number of subjects: 59
Study: 32953229

Group type: EXPERIMENTAL
Intervention: C1INH (SC) 40 or 60 IU/kg twice weekly for 52-140 weeks
Number of subjects: 10
Study: 35105177

Group type: EXPERIMENTAL
Intervention: SXC
Number of subjects: 628

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 628
Study: 33792003

Group type: EXPERIMENTAL
Intervention: Topically administered heparin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control ointment (dexpanthenol)
Number of subjects: 50
Study: 33728429

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation
Number of subjects: 218

Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AAD)
Number of subjects: 218
Study: 33093783

Group type: EXPERIMENTAL
Intervention: walk‐bike
Number of subjects: 23

Group type: COMPARATOR
Intervention: standard care
Number of subjects: 23
Study: 35108780

Group type: EXPERIMENTAL
Intervention: Low-flow anesthesia (1 L/min)
Number of subjects: 104

Group type: COMPARATOR
Intervention: High-flow anesthesia (2 L/min)
Number of subjects: 104
Study: 33757957

Group type: EXPERIMENTAL
Intervention: Activate intervention
Number of subjects: 20
Study: 32023606

Group type: EXPERIMENTAL
Intervention: Phosphate binder lanthanum carbonate
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study: 36253448

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich whey protein beverage (Resource®, Nestle Health Science)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Plain water
Number of subjects: 78
Study: 35413793

Group type: EXPERIMENTAL
Intervention: Covariate constrained randomisation with adjusted analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Worst balanced allocations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Covariate constrained randomisation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjustment for weakly prognostic covariates
Number of subjects: 0
Study: 33788459

Group type: EXPERIMENTAL
Intervention: Long-snake moxibustion combined with western medication (loperamide hydrochloride and bacillus licheniformis)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simple medication (loperamide hydrochloride and bacillus licheniformis)
Number of subjects: 60
Study: 32124570

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the stages of change (home visits, telephone calls, group training sessions, delivery of printed material)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study: 36199766

Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 5386

Group type: EXPERIMENTAL
Intervention: Random forest model
Number of subjects: 5386

Group type: EXPERIMENTAL
Intervention: Extreme Gradient Boosting model
Number of subjects: 5386

Group type: EXPERIMENTAL
Intervention: Nomogram model based on logistic regression
Number of subjects: 5386
Study: 34009679

Group type: EXPERIMENTAL
Intervention: Grit-blasted with 110 µm alumina particles (GB)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Polydopamine (PDA) coating
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 63
Study: 33139686

Group type: EXPERIMENTAL
Intervention: Exercise program (EG)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Exercise program plus lifestyle education (ELG)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 39
Study: 34915542

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham needling
Number of subjects: 43
Study: 33731305

Group type: EXPERIMENTAL
Intervention: PAL-HF intervention
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1000
Study: 32757577

Group type: COMPARATOR
Intervention: Integrated Intervention for Dual Problems and Early Action (IIDEA), a 10-session manualized intervention that includes cognitive therapy and mindfulness practice.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced treatment as usual (usual treatment plus scheduled assessments)
Number of subjects: 0
Study: 33544914

Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Post-session narrative assignment
Number of subjects: 180
Study: 32438787

Group type: EXPERIMENTAL
Intervention: Alternating sets (AST)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Straight sets (TRAD)
Number of subjects: 12
Study: 35713688

Group type: EXPERIMENTAL
Intervention: AXR + BUS
Number of subjects: 56

Group type: COMPARATOR
Intervention: AXR
Number of subjects: 56
Study: 33591618

Group type: EXPERIMENTAL
Intervention: semaglutide 0.25 mg
Number of subjects: 104

Group type: COMPARATOR
Intervention: dulaglutide 0.75 mg
Number of subjects: 104
Study: 32717294

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36153634

Group type: EXPERIMENTAL
Intervention: Online Cognitive Behavioral Therapy for Insomnia (OCBT-I) + Positive Airway Pressure (PAP) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapist-delivered Cognitive Behavioral Therapy for Insomnia (TCBT-I)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care (UC) PAP + Sleep Hygiene Education
Number of subjects: 0
Study: 33099898

Group type: EXPERIMENTAL
Intervention: nal-IRI+5-FU/LV
Number of subjects: 79

Group type: COMPARATOR
Intervention: 5-FU/LV
Number of subjects: 79
Study: 36470531

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily
Number of subjects: 6564

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6564
Study: 33638096

Group type: EXPERIMENTAL
Intervention: Carboxy therapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nd:YAG laser
Number of subjects: 28
Study: 33268431

Group type: EXPERIMENTAL
Intervention: Complex intervention consisting of education of nursing staff, awareness raising and continuing medical education (CME) of general practitioners, and multicomponent non-pharmacological group intervention MAKS-mk+ (motor training, cognitive training, fall prevention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 0
Study: 36372062

Group type: EXPERIMENTAL
Intervention: Protective Behavioral Strategies (PBS) measures (PBSS and SQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specific PBS subscales
Number of subjects: 0
Study: 34063068

Group type: EXPERIMENTAL
Intervention: NATUREN G® (synbiotic formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35729493

Group type: EXPERIMENTAL
Intervention: GPMP (General Practice Management Plans)
Number of subjects: 905
Study: 33108985

Group type: EXPERIMENTAL
Intervention: Plyometric training (PT)
Number of subjects: 116
Study: 33726793

Group type: EXPERIMENTAL
Intervention: Behavioural insights approach (n=31)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard outreach approach (n=65)
Number of subjects: 96
Study: 32639946

Group type: EXPERIMENTAL
Intervention: Survival nomogram based on five clinicopathological features (race, AJCC stage, surgery for primary site, chemotherapy, tumor size)
Number of subjects: 794

Group type: COMPARATOR
Intervention: AJCC staging system
Number of subjects: 794
Study: 36241590

Group type: EXPERIMENTAL
Intervention: Early time-restricted eating (eTRE) with a daily 6-hour eating window
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (CON) with a daily 16-hour eating window
Number of subjects: 25
Study: 33516458

Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy (n = 36)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Treatment waiting list (n = 30)
Number of subjects: 66
Study: 35273107

Group type: EXPERIMENTAL
Intervention: Cervical Disc Arthroplasty (CDA)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 397
Study: 33038066

Group type: EXPERIMENTAL
Intervention: High sodium meal (HSM; 1,495 mg Na+)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Low sodium meal (LSM; 138 mg Na+)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: High sodium meal (HSM)
Number of subjects: 37
Study: 35502340

Group type: EXPERIMENTAL
Intervention: self‐adhering FCR
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: fluoride‐releasing FCR
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: microhybrid FCR
Number of subjects: 30
Study: 36367444

Group type: COMPARATOR
Intervention: Habitat manipulation (temporary change to the environment)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Habitat manipulation with larviciding
Number of subjects: 16

Group type: COMPARATOR
Intervention: Combination of habitat manipulation and permanent change (habitat modification)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Combination of manipulation and modification with larviciding
Number of subjects: 16
Study: 37583921

Group type: EXPERIMENTAL
Intervention: Active craniocervical flexion (CCF) exercise (3 sets of 10 repetitions)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Mulligan mobilisation (3 sets of 6-10 repetitions)
Number of subjects: 26
Study: 33570517

Group type: EXPERIMENTAL
Intervention: 3 sessions (3S)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 2 sessions (2S)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 1 session (1S)
Number of subjects: 36
Study: 32434561

Group type: EXPERIMENTAL
Intervention: NNRTI-PDR testing
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: NRTI resistance mutation (M184V)
Number of subjects: 200
Study: 35986508

Group type: EXPERIMENTAL
Intervention: Sodium beta-hydroxybutyrate (BHB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 10
Study: 33839747

Group type: EXPERIMENTAL
Intervention: Pretransplant bridging therapy
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Controlled disease (under bridging therapy)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Patients with HCCs outside the Milan criteria (MC) downsized to within the MC
Number of subjects: 525
Study: 32317673

Group type: EXPERIMENTAL
Intervention: Cadmium concentration in plants (0, 10, and 100 mg kg‐1 soil)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Mercury concentration in plants (0, 2, and 20 mg kg‐1 soil)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Yield values of MxG
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Accumulation of cadmium in aboveground biomass
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Accumulation of mercury in aboveground biomass
Number of subjects: 3
Study: 35840747

Group type: EXPERIMENTAL
Intervention: Low-dose PTCy-ATG (20 mg/kg on day +3 and +4, 6 mg/kg ATG)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard-dose ATG (10 mg/kg)
Number of subjects: 104
Study: 32107343

Group type: EXPERIMENTAL
Intervention: Low-salt diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: High-salt diet
Number of subjects: 40
Study: 35906662

Group type: EXPERIMENTAL
Intervention: Usual care according to rehabilitation priorities adapted to post-COVID symptoms
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group: Patients of the post-COVID outpatient clinic without rehabilitation
Number of subjects: 1000
Study: 32918100

Group type: EXPERIMENTAL
Intervention: Developmentally adapted cognitive processing therapy (D‐CPT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Wait-list with treatment advice (WL/TA)
Number of subjects: 85
Study: 33155236

Group type: EXPERIMENTAL
Intervention: Individualized antiplatelet therapy based on CYP2C19 genotype and platelet function (IA group)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional antiplatelet therapy (CA group)
Number of subjects: 89
Study: 36086822

Group type: EXPERIMENTAL
Intervention: Stepped-wedge cluster-randomized trial
Number of subjects: 54

Group type: COMPARATOR
Intervention: Parallel-group cluster-randomized trial
Number of subjects: 54
Study: 34441009

Group type: EXPERIMENTAL
Intervention: Concomitant therapy
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Hybrid therapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Adverse events
Number of subjects: 140
Study: 36060969

Group type: EXPERIMENTAL
Intervention: MET plus LIRA therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: MET monotherapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both MET and COM
Number of subjects: 60
Study: 33269975

Group type: EXPERIMENTAL
Intervention: Nomegestrol acetate (NOMAc) 10 mg/day and transdermal 17-beta-estradiol (E2) 75 µg/week
Number of subjects: 202
Study: 35109837

Group type: EXPERIMENTAL
Intervention: Local injection of tranexamic acid (TXA)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Drain clamping
Number of subjects: 109
Study: 34762372

Group type: EXPERIMENTAL
Intervention: Scalp acupuncture electrical stimulation
Number of subjects: 54

Group type: COMPARATOR
Intervention: Routine scalp acupuncture
Number of subjects: 54
Study: 34134812

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 34870114

Group type: EXPERIMENTAL
Intervention: Physiotherapy combined with therapeutic neuroscience education (TNE)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Physiotherapy alone
Number of subjects: 31
Study: 35920762

Group type: EXPERIMENTAL
Intervention: Guselkumab treatment
Number of subjects: 664
Study: 32072618

Group type: EXPERIMENTAL
Intervention: Clinical trial evidence of a 'medication'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Clinical trial evidence of a 'topical steroid'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Anecdote of a 'medication'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Anecdote of a 'topical steroid'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Both clinical trial evidence and anecdote of a 'medication'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Both clinical trial evidence and anecdote of a 'topical steroid'
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Doctor's recommendation
Number of subjects: 476

Group type: COMPARATOR
Intervention: No information on medication's efficacy or safety profile
Number of subjects: 476
Study: 35101419

Group type: EXPERIMENTAL
Intervention: Low-dose warfarin (target INR 2.0 to 2.5)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Standard-dose warfarin (target INR 2.5 to 3.5)
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Low-dose warfarin
Number of subjects: 401

Group type: COMPARATOR
Intervention: Standard-dose warfarin
Number of subjects: 401
Study: 34472693

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 521

Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 521
Study: 32919056

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (5-6 times weekly for 60 days)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 22
Study: 33977560

Group type: EXPERIMENTAL
Intervention: Varenicline 0.5mg orally b.i.d.
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 32700461

Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 33397457

Group type: EXPERIMENTAL
Intervention: Standard of care plus 1000 mg of nitazoxanide twice daily and 300/100 mg of atazanavir/ritonavir once daily orally
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 98
Study: 32315431

Group type: EXPERIMENTAL
Intervention: Waist-shaped interdental brushes (WIBs)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Straight-shaped interdental brushes (SIBs)
Number of subjects: 20
Study: 34953787

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (N2O) cryoablation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Argon gas cryoablation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both N2O and argon cryoablation
Number of subjects: 60
Study: 35477868

Group type: EXPERIMENTAL
Intervention: Identifiable data sharing for direct clinical care without explicit consent
Number of subjects: 29275

Group type: EXPERIMENTAL
Intervention: Research sharing of de-identified data without explicit consent
Number of subjects: 29275

Group type: EXPERIMENTAL
Intervention: Sharing to NHS, academic institutions, and national research charities
Number of subjects: 29275

Group type: EXPERIMENTAL
Intervention: Sharing to profit-making companies
Number of subjects: 29275

Group type: EXPERIMENTAL
Intervention: Sharing to other companies
Number of subjects: 29275

Group type: EXPERIMENTAL
Intervention: De-identified linkage to non-health data
Number of subjects: 29275

Group type: EXPERIMENTAL
Intervention: Single NHS mechanism to choose uses of data
Number of subjects: 29275

Group type: EXPERIMENTAL
Intervention: Support for data sharing during COVID-19
Number of subjects: 29275
Study: 36254954

Group type: EXPERIMENTAL
Intervention: Manuka honey mouthrinse
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ocimum sanctum mouthrinse
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Curcuma longa mouthrinse
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine mouthrinse
Number of subjects: 80
Study: 34423474

Group type: EXPERIMENTAL
Intervention: 2-hour feeding interval (Group A)
Number of subjects: 78

Group type: COMPARATOR
Intervention: 3-hour feeding interval (Group B)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups (Group A and Group B)
Number of subjects: 78
Study: 33654379

Group type: EXPERIMENTAL
Intervention: Combination analgesia (oral celebrex, pregabalin, and subcutaneous infiltration of ropivacaine)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ropivacaine (only subcutaneous infiltration of ropivacaine)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 93
Study: 32369191

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 25
Study: 36288594

Group type: EXPERIMENTAL
Intervention: 4 mg of dexamethasone
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 8 mg of dexamethasone
Number of subjects: 63
Study: 32307295

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) distraction
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 116
Study: 32465030

Group type: EXPERIMENTAL
Intervention: ICD at the time of LVAD implantation (n=350)
Number of subjects: 574

Group type: COMPARATOR
Intervention: No ICD at the time of LVAD implantation (n=174)
Number of subjects: 574
Study: 36086061

Group type: EXPERIMENTAL
Intervention: Machine learning model using signals from a wrist wearable device
Number of subjects: 0
Study: 33242697

Group type: COMPARATOR
Intervention: Omalizumab
Number of subjects: 0